rs1412213561
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_152594.3(SPRED1):c.221G>T(p.Cys74Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152594.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPRED1 | ENST00000299084.9 | c.221G>T | p.Cys74Phe | missense_variant | Exon 3 of 7 | 1 | NM_152594.3 | ENSP00000299084.4 | ||
SPRED1 | ENST00000561317.1 | c.158G>T | p.Cys53Phe | missense_variant | Exon 4 of 6 | 4 | ENSP00000453680.1 | |||
SPRED1 | ENST00000561205.1 | n.559G>T | non_coding_transcript_exon_variant | Exon 3 of 5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: SPRED1 c.221G>T (p.Cys74Phe) results in a non-conservative amino acid change located in the WH1/EVH1 domain (IPR000697) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251148 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.221G>T has been reported in the literature in a proband affected with Neurofibromatosis Type 1-Like Syndrome (Legius Syndrome) and in the proband's asymptomatic mother (e.g. Messiaen_2009). These report(s) do not provide unequivocal conclusions about association of the variant with Neurofibromatosis Type 1-Like Syndrome (Legius Syndrome). Two publications report experimental evidence in vitro suggesting the variant does not alter protein function, without evidence to establish effect in disease setting, allowing no convincing conclusions about the variant effect (e.g. Messaien_2009, Hirata_2016). The following publications have been ascertained in the context of this evaluation (PMID: 31401120, 26635368, 19920235). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Legius syndrome Uncertain:1
This sequence change replaces cysteine, which is neutral and slightly polar, with phenylalanine, which is neutral and non-polar, at codon 74 of the SPRED1 protein (p.Cys74Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Legius syndrome (PMID: 19920235). ClinVar contains an entry for this variant (Variation ID: 468795). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is not expected to disrupt SPRED1 function with a negative predictive value of 95%. Experimental studies have shown that this missense change does not substantially affect SPRED1 function (PMID: 19920235, 26635368). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at